亚叶酸钙对治疗非小细胞肺癌的甲氨蝶呤、环磷酰胺和顺铂方案的治疗指数的改善作用。 - Suppr

Suppr

超能文献

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

作者信息

Lee J S, Libshitz H I, Fossella F V, Murphy W K, Pang A C, Lippman S M, Shin D M, Dimery I W, Glisson B S, Hong W K

机构信息

Department of Medical Oncology, UT M. D. Anderson Cancer Center, Houston 77030.

出版信息

J Natl Cancer Inst. 1992 Jul 1;84(13):1039-40. doi: 10.1093/jnci/84.13.1039.

DOI:10.1093/jnci/84.13.1039

PMID:1318977

Abstract

摘要

相似文献

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.亚叶酸钙对治疗非小细胞肺癌的甲氨蝶呤、环磷酰胺和顺铂方案的治疗指数的改善作用。

J Natl Cancer Inst. 1992 Jul 1;84(13):1039-40. doi: 10.1093/jnci/84.13.1039.

Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy.亚叶酸减轻依达曲沙的剂量限制性毒性：提高治疗效果的潜力。

Cancer Chemother Pharmacol. 1991;28(3):199-204. doi: 10.1007/BF00685509.

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.依达曲沙可增强环磷酰胺和顺铂对非小细胞肺癌的抗肿瘤作用。

Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v.

Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.抗叶酸药物依达曲沙与顺铂两种给药方案的I期及药理学研究。

Clin Cancer Res. 2001 Mar;7(3):501-9.

Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.通过中位效应分析评估依达曲沙和顺铂联合使用对A549肺癌细胞系的时间依赖性协同作用。

Cancer Chemother Pharmacol. 1993;33(3):245-50. doi: 10.1007/BF00686223.

Edatrexate studies in non-small cell lung cancer.依达曲沙在非小细胞肺癌中的研究。

Lung Cancer. 1995 Apr;12 Suppl 1:S187-91. doi: 10.1016/0169-5002(95)00435-4.

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study.

Cancer Chemother Pharmacol. 1997;41(1):75-8. doi: 10.1007/s002800050710.

An important new drug and regimen for non-small-cell lung Ca.一种用于非小细胞肺癌的重要新药及治疗方案。

Oncology (Williston Park). 1990 Oct;4(10):21.

A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.一项关于依达曲沙联合长春碱、阿霉素、顺铂和非格司亭（EVAC/G-CSF）用于晚期恶性肿瘤患者的剂量探索性试验：对非小细胞肺癌具有有前景的抗肿瘤活性。

Cancer J Sci Am. 1997 Sep-Oct;3(5):297-302.

A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.一项关于顺铂、5-氟尿嘧啶和亚叶酸钙联合长春瑞滨（诺维本）治疗晚期非小细胞肺癌的II期研究：理论依据与研究设计

Semin Oncol. 1994 Oct;21(5 Suppl 10):79-83; discussion 83-4.

引用本文的文献

Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy.预先给予亚叶酸钙可最大限度地减少普拉曲沙的毒性而不影响疗效。

Leuk Lymphoma. 2013 Nov;54(11):2448-51. doi: 10.3109/10428194.2013.779688. Epub 2013 Apr 8.

Promising new agents in the treatment of non-small cell lung cancer.

Cancer Chemother Pharmacol. 1996;37(5):385-93. doi: 10.1007/s002800050402.

Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro.紫杉醇或多西他赛与依达曲沙对人乳腺癌细胞体外的时间依赖性协同作用。

Cancer Chemother Pharmacol. 1996;37(3):222-8. doi: 10.1007/BF00688320.

Effective combination therapy of metastatic murine solid tumors with edatrexate and the vinca alkaloids, vinblastine, navelbine and vindesine.

Cancer Chemother Pharmacol. 1994;33(4):286-90. doi: 10.1007/BF00685901.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验